4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-004798
Options or other derivatives
- Director acquired 38,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sandor Victor Director | 2025-06-12 | Grant or award · Director Stock Option (Right to Buy) | +38,000 | 38,000 | D | ||
Loading xslF345X05/primarydocument.xml…